Cellectar Biosciences, Inc. Resources

Patients News & Media Investors Contact

Cellectar Biosciences, Inc.

  • Home
  • About
    • Overview
    • Partnerships
    • Management Team
    • Board of Directors
  • Platform
    • Overview
    • Posters & Publications
  • Product Pipeline
    • Overview
    • Iopofosine
  • Clinical Studies
    • Overview
    • Waldenstrom’s Macroglobulinemia Phase 2 Study Active, not recruiting
    • Relapsed or Refractory Select B-Cell Malignancies Clinical Study Active, not recruiting
    • Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG Active, not recruiting
  • Patients
  • News & Media
  • Investors
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

UPDATE -- Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update

May 4, 2023

Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update

May 4, 2023

Cellectar Reports Financial Results for Year Ended 2022 and Provides a Corporate Update

Mar 9, 2023

Cellectar to Participate at Upcoming Banking Conferences

Mar 8, 2023

Cellectar Biosciences Reports Complete Response in a Relapsed/Refractory CNS Lymphoma Patient

Feb 28, 2023

Cellectar Biosciences Hires Dr. Andrei Shustov as New Senior Vice President, Medical

Feb 15, 2023

Cellectar Biosciences Announces Shane Lea as Chief Commercial Officer

Nov 30, 2022

Cellectar Biosciences Announces Presentation of Data on CLR 12120 Series of Targeted Alpha-Emitting Therapies at the 13th Annual World ADC Conference

Nov 21, 2022

Cellectar Announces Resolution of Breach of Contract and Intellectual Property Dispute

Nov 16, 2022

Cellectar Reports Financial Results for Third Quarter 2022 and Provides a Corporate Update

Nov 3, 2022
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...36
    © 2025 Cellectar Biosciences, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap Q&A